172 related articles for article (PubMed ID: 34995873)
1. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
[TBL] [Abstract][Full Text] [Related]
2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
3. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
5. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
[TBL] [Abstract][Full Text] [Related]
6. Risks of myeloid malignancies in patients with autoimmune conditions.
Anderson LA; Pfeiffer RM; Landgren O; Gadalla S; Berndt SI; Engels EA
Br J Cancer; 2009 Mar; 100(5):822-8. PubMed ID: 19259097
[TBL] [Abstract][Full Text] [Related]
7. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database.
Wilson AB; Neogi T; Prout M; Jick S
Cancer Epidemiol; 2014 Oct; 38(5):544-9. PubMed ID: 25189344
[TBL] [Abstract][Full Text] [Related]
8. The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.
Hubbard AK; Richardson M; Rosesler MA; Cioc A; Nguyen PL; Warlick E; Poynter JN
Leuk Lymphoma; 2021 Jun; 62(6):1474-1481. PubMed ID: 33416407
[TBL] [Abstract][Full Text] [Related]
9. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
[TBL] [Abstract][Full Text] [Related]
10. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
Poynter JN; Richardson M; Langer E; Hooten AJ; Roesler M; Hirsch B; Nguyen PL; Cioc A; Warlick E; Ross JA
Genes Chromosomes Cancer; 2016 Sep; 55(9):688-93. PubMed ID: 27121678
[TBL] [Abstract][Full Text] [Related]
11. Alcohol use is not a significant contributor to myelodysplastic syndromes.
Duffy EA; Nguyen PL; Cioc A; Warlick E; Roesler MA; Poynter JN
Cancer Causes Control; 2020 Jun; 31(6):549-557. PubMed ID: 32285234
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?
Hochman MJ; DeZern AE
Lancet Haematol; 2022 Jul; 9(7):e523-e534. PubMed ID: 35772431
[TBL] [Abstract][Full Text] [Related]
13. Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis.
Adrianzen-Herrera D; Sparks AD; Singh R; Alejos-Castillo D; Batra A; Glushakow-Smith S; Pradhan K; Shastri A; Zakai NA
Blood Adv; 2023 Nov; 7(22):6913-6922. PubMed ID: 37729616
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Péan de Ponfilly-Sotier M; Jachiet V; Benhamou Y; Lahuna C; De Renzis B; Kottler D; Voillat L; Dimicoli-Salazar S; Banos A; Chauveheid MP; Alexandra JF; Grignano E; Liferman F; Laborde M; Broner J; Michel M; Lambotte O; Laribi K; Venon MD; Dussol B; Martis N; Thepot S; Park S; Couret D; Roux-Sauvat M; Terriou L; Hachulla E; Bally C; Galland J; Allain JS; Parcelier A; Peterlin P; Cohen-Bittan J; Regent A; Ackermann F; Le Guen J; Algrin C; Charles P; Daguindau E; Puechal X; Dunogue B; Blanchard-Delaunay C; Beyne-Rauzy O; Grobost V; Schmidt J; Le Gallou T; Dubos-Lascu G; Sonet A; Denis G; Roy-Peaud F; Fenaux P; Adès L; Fain O; Mekinian A;
Clin Exp Rheumatol; 2022 Jul; 40(7):1336-1342. PubMed ID: 35579092
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diseases and myelodysplastic syndromes.
Komrokji RS; Kulasekararaj A; Al Ali NH; Kordasti S; Bart-Smith E; Craig BM; Padron E; Zhang L; Lancet JE; Pinilla-Ibarz J; List AF; Mufti GJ; Epling-Burnette PK
Am J Hematol; 2016 May; 91(5):E280-3. PubMed ID: 26875020
[TBL] [Abstract][Full Text] [Related]
16. [The myelodysplastic syndrome and autoimmunity].
Laursen SB; Nielsen MØ; Hasselbalch HC
Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for myelodysplastic syndromes: a case-control study in Greece.
Dalamaga M; Petridou E; Cook FE; Trichopoulos D
Cancer Causes Control; 2002 Sep; 13(7):603-8. PubMed ID: 12296507
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors for infections in myelodysplastic syndromes.
Sullivan LR; Sekeres MA; Shrestha NK; Maciejewski JP; Tiu RV; Butler R; Mossad SB
Transpl Infect Dis; 2013 Dec; 15(6):652-7. PubMed ID: 24010918
[TBL] [Abstract][Full Text] [Related]
20. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]